Kraus JL - Search Results

1

Design and evaluation of hepatitis B virus inhibitors.

Hantz O, Kraus JL, Zoulim F. Hantz O, et al. Among authors: kraus jl. Curr Pharm Des. 2000 Mar;6(5):503-23. doi: 10.2174/1381612003400740. Curr Pharm Des. 2000. PMID: 10788594 Review.

2

Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles.

Hantz O, Borel C, Trabaud C, Zoulim F, Dessolin J, Camplo M, Vlieghe P, Bouygues M, Trepo C, Kraus JL. Hantz O, et al. Among authors: kraus jl. Antimicrob Agents Chemother. 1997 Nov;41(11):2579-81. doi: 10.1128/AAC.41.11.2579. Antimicrob Agents Chemother. 1997. PMID: 9371374 Free PMC article.

3

Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles.

Trabaud C, Dessolin J, Camplo M, Hantz O, Zoulim F, Borel C, Meyer M, Pepe G, Chermann JC, Kraus JL. Trabaud C, et al. Among authors: kraus jl. Antivir Chem Chemother. 1998 Jan;9(1):73-84. Antivir Chem Chemother. 1998. PMID: 9875379

4

Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs?

Anastasi C, Vlieghe P, Hantz O, Schorr O, Pannecouque C, Witvrouw M, De Clercq E, Clayette P, Dereuddre-Bosquet N, Dormont D, Gondois-Rey F, Hirsch I, Kraus JL. Anastasi C, et al. Among authors: kraus jl. Bioorg Med Chem Lett. 2003 Aug 4;13(15):2459-63. doi: 10.1016/s0960-894x(03)00496-7. Bioorg Med Chem Lett. 2003. PMID: 12852943

5

Potent nonclassical nucleoside antiviral drugs based on the N,N-diarylformamidine concept.

Anastasi C, Hantz O, De Clercq E, Pannecouque C, Clayette P, Dereuddre-Bosquet N, Dormont D, Gondois-Rey F, Hirsch I, Kraus JL. Anastasi C, et al. Among authors: kraus jl. J Med Chem. 2004 Feb 26;47(5):1183-92. doi: 10.1021/jm0309708. J Med Chem. 2004. PMID: 14971898

6

Prospects for the resistance to HIV protease inhibitors: current drug design approaches and perspectives.

Burlet S, Pietrancosta N, Laras Y, Garino C, Quéléver G, Kraus JL. Burlet S, et al. Among authors: kraus jl. Curr Pharm Des. 2005;11(24):3077-90. doi: 10.2174/1381612054864939. Curr Pharm Des. 2005. PMID: 16178746 Review.

7

New antiviral nucleoside prodrugs await application.

Anastasi C, Quéléver G, Burlet S, Garino C, Souard F, Kraus JL. Anastasi C, et al. Among authors: kraus jl. Curr Med Chem. 2003 Sep;10(18):1825-43. doi: 10.2174/0929867033457034. Curr Med Chem. 2003. PMID: 12871107 Review.

8

Synthesis and biological evaluation of polyaminated 2',3'-dideoxy-3'-thiacytidine prodrugs.

Camplo M, Mourier N, Chermann JC, Kraus JL. Camplo M, et al. Among authors: kraus jl. Nucleosides Nucleotides. 1999 Apr-May;18(4-5):879-80. doi: 10.1080/15257779908041590. Nucleosides Nucleotides. 1999. PMID: 10432700

9

Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays.

Garino C, Tomita T, Pietrancosta N, Laras Y, Rosas R, Herbette G, Maigret B, Quéléver G, Iwatsubo T, Kraus JL. Garino C, et al. Among authors: kraus jl. J Med Chem. 2006 Jul 13;49(14):4275-85. doi: 10.1021/jm0602864. J Med Chem. 2006. PMID: 16821787

10

New bicyclam-AZT conjugates: design, synthesis, anti-HIV evaluation, and their interaction with CXCR-4 coreceptor.

Dessolin J, Galea P, Vlieghe P, Chermann JC, Kraus JL. Dessolin J, et al. Among authors: kraus jl. J Med Chem. 1999 Jan 28;42(2):229-41. doi: 10.1021/jm980358u. J Med Chem. 1999. PMID: 9925728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters